Drugs that help people hold on to their muscles while losing fat are becoming one of the hottest trends in biotech.

Scholar Rock’s Isembyld isn’t the only FDA-approved therapy for spinal muscular atrophy, but it is the first one that ...

Does Ozempic cause muscle loss? A 2026 meta-analysis of 15,000+ patients reveals the truth about GLP-1 weight loss vs. dieting—and how lifters can keep 100% of their hard-earned muscle.

Glucagon-like peptide-1 (GLP-1) receptor agonists — also known as GLP-1 drugs — have gained a significant amount of attention in recent years because of their utility in managing type 2 diabetes (T2D) ...

Thinking about taking Ozempic but worried about losing too much muscle? New clinical trial data might point to a future where that’s no longer a concern. Regeneron Pharmaceuticals announced the ...

Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss. But along with the fat, many are quietly losing something else: muscle. Unlike fat, muscle doesn ...

New medications to treat obesity have helped many people lose significant amounts of weight, but some of that weight loss inevitably comes from muscle loss. Ozempic, Wegovy, Mounjaro and Zepbound are ...

The Food and Drug Administration approved Isembyld on September 11, granting it Fast Track, Orphan Drug, and Rare Pediatric ...

An experimental oral drug claims to do the work of medications like GLP-1s without losing muscle mass. The medication just went through phase 1 clinical trials. Doctors explain the new medication and ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? There are two drugs, currently in clinical trials, aiming to help patients ...

For a little over a century, modern weight loss medications have worked to provide a slimming solution that mature adults can count on. Subsequently, reduction drugs such as glucagon-like peptide-1 ...

The failure of “del-desiran,” which Novartis got through a $12 billion acquisition, could raise questions about the company’s ...